Literature DB >> 9848113

Differential sensitivity of chromium-mediated DNA interstrand crosslinks and DNA-protein crosslinks to disruption by alkali and EDTA.

J Singh1, L C Bridgewater, S R Patierno.   

Abstract

Some compounds of hexavalent chromium are well-established carcinogens. Chromium enters mammalian cells in the hexavalent form and is reduced to chromium (III). Treatment of purified DNA with chromium (III) produces DNA-DNA interstrand crosslinks (DDC) which obstruct the progression of DNA polymerases in vitro. DDC were also detected in chromate-treated cultured normal human lung cells using the renaturing agarose gel electrophoresis (RAGE) assay and correlated with base-specific inhibition of DNA replication. Curiously, DDC have gone undetected in studies of cultured cells using the alkaline elution (AE) technique, whereas chromium-mediated DNA-protein crosslinks (DPC) were readily detected by AE. We tested the hypothesis that AE conditions [60 mM tetraethyl ammonium hydroxide (TEA), 20 mM EDTA, pH 12.6, for 16 h at room temperature] dissociate DDC but not DPC using chromium(III)-treated plasmid DNA and the RAGE assay. Dose-dependent chromium-induced DDC were unaffected by TEA (pH 11.8) alone or by more rigorous alkaline denaturation conditions (200 mM NaOH, pH 13.5, for 16 h). DDC were, however, completely disrupted by EDTA (pH 12.6) alone or the combination of TEA and EDTA (pH 12.6). In contrast, DPC remained largely intact under these conditions. Therefore, past AE-based studies which have failed to detect chromium-induced DDC do not prove the absence of this lesion. AE may not be suitable for detecting DDC induced by EDTA-chelatable agents such as metals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848113     DOI: 10.1006/toxs.1998.2489

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  6 in total

1.  Binding of chromium(VI) to histones: implications for chromium(VI)-induced genotoxicity.

Authors:  Aviva Levina; Hugh H Harris; Peter A Lay
Journal:  J Biol Inorg Chem       Date:  2005-12-15       Impact factor: 3.358

2.  FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.

Authors:  Susan K Vilcheck; Susan Ceryak; Travis J O'Brien; Steven R Patierno
Journal:  Mutat Res       Date:  2006-08-08       Impact factor: 2.433

3.  Resistance to apoptosis, increased growth potential, and altered gene expression in cells that survived genotoxic hexavalent chromium [Cr(VI)] exposure.

Authors:  Daryl E Pritchard; Susan Ceryak; Keri E Ramsey; Travis J O'Brien; Linan Ha; Jamie L Fornsaglio; Dietrich A Stephan; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

4.  Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK.

Authors:  Susan Ceryak; Carla Zingariello; Travis O'Brien; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

5.  Fanconi anemia complementation group A cells are hypersensitive to chromium(VI)-induced toxicity.

Authors:  Susan K Vilcheck; Travis J O'Brien; Daryl E Pritchard; Linan Ha; Susan Ceryak; Jamie L Fornsaglio; Steven R Patierno
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

6.  Oxidative stress-related mechanisms are associated with xenobiotics exerting excess toxicity to Fanconi anemia cells.

Authors:  Giovanni Pagano; Paola Manini; Debasis Bagchi
Journal:  Environ Health Perspect       Date:  2003-11       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.